• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Basic Materials·601208.SS
Share

Sichuan Em Technology Co., Ltd. Stocks

CN¥ 49.16Last Updated 30.09.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 7.27B

CN¥ 49.16
Key Takeaways

Risk factor

Good trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Sichuan Em Technology Co., Ltd., based in Mianyang, China, is a company primarily engaged in the research, development, production, and sale of advanced materials across China. The firm offers a wide array of specialized products, including various types of films such as electrical and electronic insulation films, optical PET films, polyester films, capacitor PP films, PVB resins and films, as well as polycarbonate and polypropylene films and sheets. Additionally, its extensive portfolio features electrical insulation materials, composite materials, thermosetting composites, flame retardant substances, and unique resins. The company also supplies PET chips, adhesive tapes, protection films, fabricated products, resin specifically for CCL (Copper Clad Laminates), and active pharmaceutical ingredients (APIs) along with their intermediates.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 601208.SS is 60.7 and suggests 25.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 09:30

Citrini, who spooked the market, announced a “new paradigm” in the crypto market. What does AI have to do with it?

09.10.2026 08:30

The Hot Potato Game: Why Does Wall Street Prefer Chipmakers Over AI Developers?

09.10.2026 07:30

Trump disclosed major trades in SpaceX and Nvidia stocks and awarded their CEOs medals

09.10.2026 05:11

Lukoil's overseas assets are once again up for sale: the deal with Carlyle fell through

09.10.2026 03:50

Blue Origin funding round makes Bezos world’s second-richest person

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026